Literature DB >> 33184580

Scaffold Architecture and Matrix Strain Modulate Mesenchymal Cell and Microvascular Growth and Development in a Time Dependent Manner.

Gennifer Chiou1, Elysa Jui1, Allison C Rhea1, Aparna Gorthi2, Solaleh Miar1, Francisca M Acosta1, Cynthia Perez1, Yasir Suhail3, Yidong Chen2, Joo L Ong1, Rena Bizios1, Christopher Rathbone1, Teja Guda1.   

Abstract

BACKGROUND: Volumetric tissue-engineered constructs are limited in development due to the dependence on well-formed vascular networks. Scaffold pore size and the mechanical properties of the matrix dictates cell attachment, proliferation and successive tissue morphogenesis. We hypothesize scaffold pore architecture also controls stromal-vessel interactions during morphogenesis.
METHODS: The interaction between mesenchymal stem cells (MSCs) seeded on hydroxyapatite scaffolds of 450, 340, and 250 μm pores and microvascular fragments (MVFs) seeded within 20 mg/mL fibrin hydrogels that were cast into the cell-seeded scaffolds, was assessed in vitro over 21 days and compared to the fibrin hydrogels without scaffold but containing both MSCs and MVFs. mRNA sequencing was performed across all groups and a computational mechanics model was developed to validate architecture effects on predicting vascularization driven by stiffer matrix behavior at scaffold surfaces compared to the pore interior.
RESULTS: Lectin staining of decalcified scaffolds showed continued vessel growth, branching and network formation at 14 days. The fibrin gel provides no resistance to spread-out capillary networks formation, with greater vessel loops within the 450 μm pores and vessels bridging across 250 μm pores. Vessel growth in the scaffolds was observed to be stimulated by hypoxia and successive angiogenic signaling. Fibrin gels showed linear fold increase in VEGF expression and no change in BMP2. Within scaffolds, there was multiple fold increase in VEGF between days 7 and 14 and early multiple fold increases in BMP2 between days 3 and 7, relative to fibrin. There was evidence of yap/taz based hippo signaling and mechanotransduction in the scaffold groups. The vessel growth models determined by computational modeling matched the trends observed experimentally.
CONCLUSION: The differing nature of hypoxia signaling between scaffold systems and mechano-transduction sensing matrix mechanics were primarily responsible for differences in osteogenic cell and microvessel growth. The computational model implicated scaffold architecture in dictating branching morphology and strain in the hydrogel within pores in dictating vessel lengths. © Biomedical Engineering Society 2020.

Entities:  

Keywords:  Bone; Capillaries; Scaffold; Stroma; Vascularization

Year:  2020        PMID: 33184580      PMCID: PMC7596170          DOI: 10.1007/s12195-020-00648-7

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  74 in total

1.  Dependence of intertrabecular permeability on flow direction and anatomic site.

Authors:  E A Nauman; K E Fong; T M Keaveny
Journal:  Ann Biomed Eng       Date:  1999 Jul-Aug       Impact factor: 3.934

2.  A Plugin Framework for Extending the Simulation Capabilities of FEBio.

Authors:  Steve A Maas; Steven A LaBelle; Gerard A Ateshian; Jeffrey A Weiss
Journal:  Biophys J       Date:  2018-09-26       Impact factor: 4.033

3.  Guided bone regeneration in long-bone defects with a structural hydroxyapatite graft and collagen membrane.

Authors:  Teja Guda; John A Walker; Brian M Singleton; Jesus W Hernandez; Jun-Sik Son; Su-Gwan Kim; Daniel S Oh; Mark R Appleford; Joo L Ong; Joseph C Wenke
Journal:  Tissue Eng Part A       Date:  2012-09-14       Impact factor: 3.845

Review 4.  Mechanical interaction of angiogenic microvessels with the extracellular matrix.

Authors:  Lowell T Edgar; James B Hoying; Urs Utzinger; Clayton J Underwood; Laxminarayanan Krishnan; Brenda K Baggett; Steve A Maas; James E Guilkey; Jeffrey A Weiss
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

Review 5.  The early fracture hematoma and its potential role in fracture healing.

Authors:  Paula Kolar; Katharina Schmidt-Bleek; Hanna Schell; Timo Gaber; Daniel Toben; Gerhard Schmidmaier; Carsten Perka; Frank Buttgereit; Georg N Duda
Journal:  Tissue Eng Part B Rev       Date:  2010-08       Impact factor: 6.389

6.  Vascularized versus non-vascularized bone grafts in the treatment of scaphoid non-union.

Authors:  Christoph Hirche; Lingyun Xiong; Christian Heffinger; Matthias Münzberg; Sebastian Fischer; Ulrich Kneser; Thomas Kremer
Journal:  J Orthop Surg (Hong Kong)       Date:  2017-01       Impact factor: 1.118

7.  Human mesenchymal stem cell adhesion and proliferation in response to ceramic chemistry and nanoscale topography.

Authors:  A J Dulgar-Tulloch; R Bizios; R W Siegel
Journal:  J Biomed Mater Res A       Date:  2009-08       Impact factor: 4.396

8.  Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering.

Authors:  Keun-Hong Park; Hyemin Kim; Sumi Moon; Kun Na
Journal:  J Biosci Bioeng       Date:  2009-12       Impact factor: 2.894

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Stromal Cells Promote Neovascular Invasion Across Tissue Interfaces.

Authors:  Hannah A Strobel; Steven A LaBelle; Laxminarayanan Krishnan; Jacob Dale; Adam Rauff; A Marsh Poulson; Nathan Bader; Jason E Beare; Klevis Aliaj; Jeffrey A Weiss; James B Hoying
Journal:  Front Physiol       Date:  2020-08-14       Impact factor: 4.566

View more
  1 in total

1.  Engineering Functional Vascularized Beige Adipose Tissue from Microvascular Fragments of Models of Healthy and Type II Diabetes Conditions.

Authors:  Francisca M Acosta; Katerina Stojkova; Jingruo Zhang; Eric Ivan Garcia Huitron; Jean X Jiang; Christopher R Rathbone; Eric M Brey
Journal:  J Tissue Eng       Date:  2022-06-24       Impact factor: 7.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.